• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Chem Lab Med . Rapid Identification of SARS-CoV-2-infected Patients at the Emergency Department Using Routine Testing

tetano

Editor, Senior Moderator
Clin Chem Lab Med


. 2020 Jun 29;/j/cclm.ahead-of-print/cclm-2020-0593/cclm-2020-0593.xml.
doi: 10.1515/cclm-2020-0593. Online ahead of print.
Rapid Identification of SARS-CoV-2-infected Patients at the Emergency Department Using Routine Testing

Steef Kurstjens[SUP] 1 [/SUP], Armando van der Horst[SUP] 1 [/SUP], Robert Herpers[SUP] 2 [/SUP], Mick W L Geerits[SUP] 3 [/SUP], Yvette C M Kluiters-de Hingh[SUP] 4 [/SUP], Eva-Leonne G?ttgens[SUP] 5 [/SUP], Martinus J T Blaauw[SUP] 6 [/SUP], Marc H M Thelen[SUP] 5 7 8 [/SUP], Marc G L M Elisen[SUP] 4 9 [/SUP], Ron Kusters[SUP] 1 10 [/SUP]


AffiliationsExpand

Abstract

Objectives The novel coronavirus disease 19 (COVID-19), caused by SARS-CoV-2, spreads rapidly across the world. The exponential increase in the number of cases has resulted in overcrowding of emergency departments (ED). Detection of SARS-CoV-2 is based on an RT-PCR of nasopharyngeal swab material. However, RT-PCR testing is time-consuming and many hospitals deal with a shortage of testing materials. Therefore, we aimed to develop an algorithm to rapidly evaluate an individual's risk of SARS-CoV-2 infection at the ED. Methods In this multicenter retrospective study, routine laboratory parameters (C-reactive protein, lactate dehydrogenase, ferritin, absolute neutrophil and lymphocyte counts), demographic data and the chest X-ray/CT result from 967 patients entering the ED with respiratory symptoms were collected. Using these parameters, an easy-to-use point-based algorithm, called the corona-score, was developed to discriminate between patients that tested positive for SARS-CoV-2 by RT-PCR and those testing negative. Computational sampling was used to optimize the corona-score. Validation of the model was performed using data from 592 patients. Results The corona-score model yielded an area under the receiver operating characteristic curve of 0.91 in the validation population. Patients testing negative for SARS-CoV-2 showed a median corona-score of 3 vs. 11 (scale 0-14) in patients testing positive for SARS-CoV-2 (p<0.001). Using cut-off values of 4 and 11 the model has a sensitivity and specificity of 96 and 95%, respectively. Conclusions The corona-score effectively predicts SARS-CoV-2 RT-PCR outcome based on routine parameters. This algorithm provides the means for medical professionals to rapidly evaluate SARS-CoV-2 infection status of patients presenting at the ED with respiratory symptoms.

Keywords: COVID-19; SARS-CoV-2; algorithm; coronavirus; emergency department; pandemic; prediction-model.
 
Back
Top Bottom